Candel Therapeutics, Inc. - CADL
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 02, 2026 | — | A | A | 2,795.0 | 4.114 | 11,498.63 | 2,795.0 | View | |
| Apr 02, 2026 | — | A | A | 4,618.0 | 4.114 | 18,998.45 | 4,618.0 | View | |
| Apr 02, 2026 | — | A | A | 779.0 | 4.114 | 3,204.81 | 779.0 | View | |
| Feb 26, 2026 | — | P | A | 550,458.0 | 5.45 | 2,999,996.1 | 2,763,527.0 | View | |
| Jan 28, 2026 | Chief Technology Officer | A | A | 154,000.0 | 0.0 | 0.0 | 154,000.0 | View | |
| Jan 28, 2026 | Chief Medical Officer | A | A | 136,500.0 | 0.0 | 0.0 | 136,500.0 | View | |
| Jan 28, 2026 | Chief Financial Officer | A | A | 232,000.0 | 0.0 | 0.0 | 232,000.0 | View | |
| Jan 28, 2026 | Chief Executive Officer | A | A | 629,000.0 | 0.0 | 0.0 | 629,000.0 | View | |
| Jan 28, 2026 | Chief Scientific Officer | A | A | 232,000.0 | 0.0 | 0.0 | 232,000.0 | View |